EUVIMEDEUVIMED entdecken
Crossref

Colonoscopy findings in patients with a positive FIT (Fecal Immunochemical Test)

L. C. Chavez, J. A. Ruiz, E. Jasso Baltazar, C. Zubia, J. C. Ticona, A. Saul

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S463-S464

DOI: 10.1055/s-0044-1783872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von L. C. Chavez und 5 weiteren Autor:innen. Die Arbeit nennt 2 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Fecal Immunochemical Test (FIT) is increasingly recognized as an effective and practical colorectal cancer (CRC) screening tool, more cost-effective than colonoscopy, making it a suitable option for resource-limited settings. Ensuring that individuals with positive FIT results have timely access to follow-up colonoscopy is a significant challenge. This study aims to describe the most common findings in colonoscopy among patients with a positive fecal immunochemical test (FIT).

Methods

A cross-sectional study was conducted on patients who underwent FIT with a positive result (>20 mcg Hb/g feces) and subsequent colonoscopy within 12 months, from January 2020 to October 2022, at a Mexican tertiary center. Exclusions were made for colonoscopies related to gastrointestinal bleeding, cancer surveillance, cancer screening in inflammatory bowel diseases (IBD), disease activity evaluation in IBD, surgical modification of the colon, or inadequate bowel preparation. Electronic records were reviewed for demographic characteristics and endoscopic findings. Participants were categorized into three groups based on colonoscopy results: malignant findings, non-malignant findings, and normal. Group differences were assessed, and FIT result dispersion was analyzed, for this abstract only descriptive statistics were employed for data analysis.

Results

Out of 11,375 FIT results screened, 514 were positive, and 203 participants underwent colonoscopy within the timeframe (median time of 111 days); 72 met exclusion criteria. The analysis included 131 colonoscopies, revealing 20 normal cases, 95 with non-malignant findings (diverticula, non-advanced polyps, vascular lesions, anorectal disease, inflammatory findings), and 13 with malignant (including 5 colorectal cancer cases). Median FIT results were 33 mcg Hb/g feces (IQR 28-136) for normal colonoscopies, 89 mcg Hb/g feces (IQR 36-168) for non-malignant findings, and 69 mcg Hb/g feces (IQR 34-299) for malignant findings.

Conclusions

FIT results tend to be higher in subjects with non-malignant colon pathology. The result should not cause stress in the physician or the patient and should be interpreted in the appropriate clinical context; a higher result does not necessarily translate to a higher probability of cancer. Although FIT results should always be confirmed with a colonoscopy, our findings could help prioritize urgent endoscopic studies, particularly in locations with limited access to colonoscopy such as Latin American countries. [ 1 ] [ 2 ] Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Chavez, L. C., Ruiz, J. A., Baltazar, E. J., Zubia, C., Ticona, J. C., & Saul, A. (2024). Colonoscopy findings in patients with a positive FIT (Fecal Immunochemical Test). Endoscopy, 56(S 02 S 02), S463-S464. https://doi.org/10.1055/s-0044-1783872

Vancouver

Chavez LC, Ruiz JA, Baltazar EJ, Zubia C, Ticona JC, Saul A. Colonoscopy findings in patients with a positive FIT (Fecal Immunochemical Test). Endoscopy. 2024;56(S 02 S 02):S463-S464. doi:10.1055/s-0044-1783872

BibTeX
@article{Chavez2024,
  author = {Chavez, L. C. and Ruiz, J. A. and Baltazar, E. Jasso and Zubia, C. and Ticona, J. C. and Saul, A.},
  title = {Colonoscopy findings in patients with a positive FIT (Fecal Immunochemical Test)},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S463--S464},
  doi = {10.1055/s-0044-1783872}
}
Kostenlos starten →